The Enterprise Europe Network is opening the doors for small- and medium-sized enterprises (SMEs) to key international markets, with new branches to open in India and Canada and a reinforced presence in China.
This was announced at the Network's annual conference in Cyprus on Monday. India is the latest country set to join the Network, with three new centers to start operating in New Delhi. An office will also shortly open in Canada, while four new branches in Shanghai and Nanjing have brought China's total to 27, the European Commission said in a press release on Monday.
The EU-funded business and innovation support network, based in nearly 600 local organizations in 52 countries, eases the way for companies to start trading abroad, find business or technology partners and access EU funding. Its presence in Europe, the Middle East, Asia and the Americas gives SMEs a foothold in established and emerging global markets.
European Commission Commissioner for Industry and Entrepreneurship Antonio Tajani said: "Europe's small and medium-sized enterprises need access to the global economy if they are to flourish. The Enterprise Europe Network has a strong track record in supporting small business overseas, where EU SMEs have the opportunity to benefit from new export markets, foreign partnerships and cross-border clustering. These new Network branches in Asia and Canada will create even more opportunities for companies."
Set up in 2008, the Enterprise Europe Network has been in contact with more than two million SMEs each year. For the partnership services, on average, the impact on turnover was EUR 220,000 per company. The total impact on sales growth is estimated at EUR 450 million. The Network's partnership services generate about 1,000 additional jobs every year.
Four SMEs won Network Stars Awards at the annual conference. The Network helped Polish tire firm SME Orzel SA to reach a deal with Austrian company WIL AG to set up a recycling line on its premises in Poland and expand its business abroad.
Having linked up through the Network, Swedish company Biovica International and British SME Sentinel Oncology are researching a promising new treatment against leukemia, supported by EUR 500,000 in EU funding.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org